妊娠剧吐引起的Wernicke-Korsakoff综合征

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Vaishnavi Jagat Patel, Jennifer Vu, Gisela Mercado, Sreenivas Avula, Shad Deering
{"title":"妊娠剧吐引起的Wernicke-Korsakoff综合征","authors":"Vaishnavi Jagat Patel, Jennifer Vu, Gisela Mercado, Sreenivas Avula, Shad Deering","doi":"10.1097/fm9.0000000000000198","DOIUrl":null,"url":null,"abstract":"To editor: Wernicke encephalopathy (WE) is an acute neurological disorder caused by a deficiency of vitamin B1 (thiamine), with a prevalence of 1.3% in autopsy studies.1 Eighty-four percent of patients with WE will develop Korsakoff syndrome, which is characterized by amnesia and confusion.2 Although WE is more common in alcoholics, it can also be caused by vomiting, malnourishment, and other situations. Hyperemesis gravidarum, a severe form of vomiting in pregnancy affecting 0.3% to 3% of pregnancies, can also cause thiamine deficiency.3 Although there are no specific diagnostic criteria for hyperemesis gravidarum, it is generally defined as persistent vomiting in pregnancy that has no other identifiable cause. Risk factors of hyperemesis gravidarum include a family history of hyperemesis, multiple gestation, and history of hyperemesis gravidarum. Hyperemesis gravidarum can be associated with other complications such as nutritional deficiencies, esophageal injury, psychosocial effects, and poor fetal outcomes.3 We report a case of WE associated with hyperemesis gravidarum. This case suggests that providers should have a high degree of suspicion for WE and initiate early treatment in pregnant women with severe vomiting and neurologic symptoms.4 The patient provided informed consent for publication of this case. Case presentation A 16-year-old (gravida 1, para 0) patient was transferred to our institution from a local emergency department for inpatient care at 15+4 weeks of gestation secondary to hyperemesis, altered mental status, slurred speech, difficulty ambulating, visual changes, and difficulty hearing. Her mother reported nausea and vomiting for the past 2 months with emesis occurring 4 times a day. The family also reported other symptoms such as progressive weakness, amnesia, and excessive somnolence. She had a history of generalized anxiety disorder, major depressive disorder, and one prior episode of intentional overdose of acetaminophen before pregnancy. It is possible that her symptoms were not recognized earlier due to this history as the mother stated that the patient liked to be alone. She denied tobacco, alcohol, or drug use and did not have any other known risk factors for hyperemesis gravidarum. Initial examination at the outside emergency department showed that the patient had notable ataxia and was not oriented to time or location. However, she was able to follow simple commands and answer straightforward questions. At this time, differential diagnoses for her included metabolic encephalopathy, drug abuse, alcohol intoxication, intracranial hemorrhage, cerebrovascular accident, cavernous sinus thrombosis, hyperemesis gravidarum, viral syndrome, and seizures. Laboratory results, including complete blood count, alcohol level, urine drug screen and urinalysis, were all negative. A complete metabolic panel showed hypokalemia to 2.7 mEq/L. A computed tomography of the head with contrast was initially obtained to rule out acute intracranial abnormalities and was unremarkable. OB/GYN consultation was obtained and transfer with inpatient admission was recommended. After the transfer was accepted, she was given an initial dose of thiamine 100 mg intravenously (IV) and ondansetron while en route to our hospital. Because of the patient’s clinical picture, neurology consultation was obtained, and a magnetic resonance imaging (MRI) was performed. Routine multiplanar, multisequence, T2-weighted, diffusion-weighted, fluid-attenuated inversion recovery MRI of the brain showed symmetrical, abnormal restriction in the pulvinar and dorsomedial thalamic nuclei known as the “double hockey-stick sign” and the hyperintensity in the thalami, midbrain, and peri-aqueduct area, which are findings known to be associated with WE (Figure 1A and B).5Figure 1: Findings of brain magnetic resonance imaging with T2-weighted fluid-attenuated inversion recovery sequence. A On readmission with hyperemesis (white indicate double hockey-stick sign and the hyperintensity). B At 2 months after treatment with thiamine.The patient was started on thiamine 500 mg IV twice a day for 3 days followed by 250 mg IV for 5 days in addition to a multivitamin injection, folic acid, and vitamin B6. She was also started on famotidine in addition to scheduled ondansetron and doxylamine succinate/pyridoxine three times daily. Throughout her 10-day hospital stay, her condition significantly improved, and she had full resolution of her nausea, emesis, and abdominal pain. With resolution of the acute symptoms of WE, she was discharged to home with close follow-up. She was prescribed thiamine 100 mg daily and continued on doxylamine with pyridoxine, ondansetron, famotidine, and various prenatal supplements. At neurology follow-up 2 months after discharge, the patient complained of blurry vision in her left eye. On examination, left eye esotropia and ophthalmoplegia were noted, although it had improved from her previous examination. She also continued to have some difficulty in tandem gait. No other neurological deficits were seen at this time. A repeat MRI of the brain showed resolution of the previous abnormalities on the prior MRI study (Figure 1C). Approximately 4 months after discharge, the patient was admitted for induction of labor, and she had an uncomplicated spontaneous vaginal delivery at 39 weeks of gestation. The baby had Apgar scores of 7/8 and a birth weight of 2920 g. She had minimal blood loss and recovered well after delivery. She was discharged to home in stable condition. After delivery, the patient continued to follow up with neurology regularly and had slow improvement of her left eye abnormalities and gait with continued thiamine supplementation. Follow-up 14 months after discharge showed improvement of her tandem gait and full resolution of her left eye esotropia and ophthalmoplegia. Because of normal thiamine level and improvement in her symptoms, supplementation was discontinued. She continues to follow up with neurology and ophthalmology on a regular basis to monitor gait, thiamine levels, and vision. Discussion WE has many potential risk factors such as alcohol abuse, repeated vomiting, malignancy, gastrointestinal issues, and malnutrition—all of which cause thiamine deficiency.1 While hyperemesis gravidarum can also result in acute thiamine deficiency, it is not often associated with WE. WE presents with a triad of symptoms including ocular signs, ataxia, and confusion, and its presence during pregnancy may put patients at risk for permanent neurological dysfunction, Korsakoff syndrome, miscarriage, preterm birth, intrauterine growth restriction, and death.2,5,6 Although 70% to 90% of pregnant women experience nausea and vomiting, few develop hyperemesis gravidarum. Women who are experiencing prolonged or excessive vomiting should receive thiamine supplementation (usual dosing is 100 mg intramuscular (IM) or IV) to reduce the potential development of WE; however, higher doses are warranted when WE is diagnosed.4 Recommended dosing for thiamine supplementation in WE is 500 mg IV three times daily for 2 days, followed by 250 mg IV or IM once daily for an additional 5 days.7 It is important to emphasize the correct dosing for thiamine as inadequate thiamine dosing was reported in 63% of cases in the largest systematic review (177 cases). Age may also impact the severity of WE symptoms, with younger patients potentially having better outcomes, although more evidence is needed to say this with certainty.8 In our literature review, we were not able to identify a patient as young as ours. Providers must maintain a high index of suspicion for WE and monitor for ocular signs, ataxia, and confusion. Aggressive treatment with adequate thiamine dosing is critical to avoid potentially life-threatening complications for both the mother and fetus.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2023-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Wernicke-Korsakoff Syndrome from Hyperemesis Gravidarum\",\"authors\":\"Vaishnavi Jagat Patel, Jennifer Vu, Gisela Mercado, Sreenivas Avula, Shad Deering\",\"doi\":\"10.1097/fm9.0000000000000198\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To editor: Wernicke encephalopathy (WE) is an acute neurological disorder caused by a deficiency of vitamin B1 (thiamine), with a prevalence of 1.3% in autopsy studies.1 Eighty-four percent of patients with WE will develop Korsakoff syndrome, which is characterized by amnesia and confusion.2 Although WE is more common in alcoholics, it can also be caused by vomiting, malnourishment, and other situations. Hyperemesis gravidarum, a severe form of vomiting in pregnancy affecting 0.3% to 3% of pregnancies, can also cause thiamine deficiency.3 Although there are no specific diagnostic criteria for hyperemesis gravidarum, it is generally defined as persistent vomiting in pregnancy that has no other identifiable cause. Risk factors of hyperemesis gravidarum include a family history of hyperemesis, multiple gestation, and history of hyperemesis gravidarum. Hyperemesis gravidarum can be associated with other complications such as nutritional deficiencies, esophageal injury, psychosocial effects, and poor fetal outcomes.3 We report a case of WE associated with hyperemesis gravidarum. This case suggests that providers should have a high degree of suspicion for WE and initiate early treatment in pregnant women with severe vomiting and neurologic symptoms.4 The patient provided informed consent for publication of this case. Case presentation A 16-year-old (gravida 1, para 0) patient was transferred to our institution from a local emergency department for inpatient care at 15+4 weeks of gestation secondary to hyperemesis, altered mental status, slurred speech, difficulty ambulating, visual changes, and difficulty hearing. Her mother reported nausea and vomiting for the past 2 months with emesis occurring 4 times a day. The family also reported other symptoms such as progressive weakness, amnesia, and excessive somnolence. She had a history of generalized anxiety disorder, major depressive disorder, and one prior episode of intentional overdose of acetaminophen before pregnancy. It is possible that her symptoms were not recognized earlier due to this history as the mother stated that the patient liked to be alone. She denied tobacco, alcohol, or drug use and did not have any other known risk factors for hyperemesis gravidarum. Initial examination at the outside emergency department showed that the patient had notable ataxia and was not oriented to time or location. However, she was able to follow simple commands and answer straightforward questions. At this time, differential diagnoses for her included metabolic encephalopathy, drug abuse, alcohol intoxication, intracranial hemorrhage, cerebrovascular accident, cavernous sinus thrombosis, hyperemesis gravidarum, viral syndrome, and seizures. Laboratory results, including complete blood count, alcohol level, urine drug screen and urinalysis, were all negative. A complete metabolic panel showed hypokalemia to 2.7 mEq/L. A computed tomography of the head with contrast was initially obtained to rule out acute intracranial abnormalities and was unremarkable. OB/GYN consultation was obtained and transfer with inpatient admission was recommended. After the transfer was accepted, she was given an initial dose of thiamine 100 mg intravenously (IV) and ondansetron while en route to our hospital. Because of the patient’s clinical picture, neurology consultation was obtained, and a magnetic resonance imaging (MRI) was performed. Routine multiplanar, multisequence, T2-weighted, diffusion-weighted, fluid-attenuated inversion recovery MRI of the brain showed symmetrical, abnormal restriction in the pulvinar and dorsomedial thalamic nuclei known as the “double hockey-stick sign” and the hyperintensity in the thalami, midbrain, and peri-aqueduct area, which are findings known to be associated with WE (Figure 1A and B).5Figure 1: Findings of brain magnetic resonance imaging with T2-weighted fluid-attenuated inversion recovery sequence. A On readmission with hyperemesis (white indicate double hockey-stick sign and the hyperintensity). B At 2 months after treatment with thiamine.The patient was started on thiamine 500 mg IV twice a day for 3 days followed by 250 mg IV for 5 days in addition to a multivitamin injection, folic acid, and vitamin B6. She was also started on famotidine in addition to scheduled ondansetron and doxylamine succinate/pyridoxine three times daily. Throughout her 10-day hospital stay, her condition significantly improved, and she had full resolution of her nausea, emesis, and abdominal pain. With resolution of the acute symptoms of WE, she was discharged to home with close follow-up. She was prescribed thiamine 100 mg daily and continued on doxylamine with pyridoxine, ondansetron, famotidine, and various prenatal supplements. At neurology follow-up 2 months after discharge, the patient complained of blurry vision in her left eye. On examination, left eye esotropia and ophthalmoplegia were noted, although it had improved from her previous examination. She also continued to have some difficulty in tandem gait. No other neurological deficits were seen at this time. A repeat MRI of the brain showed resolution of the previous abnormalities on the prior MRI study (Figure 1C). Approximately 4 months after discharge, the patient was admitted for induction of labor, and she had an uncomplicated spontaneous vaginal delivery at 39 weeks of gestation. The baby had Apgar scores of 7/8 and a birth weight of 2920 g. She had minimal blood loss and recovered well after delivery. She was discharged to home in stable condition. After delivery, the patient continued to follow up with neurology regularly and had slow improvement of her left eye abnormalities and gait with continued thiamine supplementation. Follow-up 14 months after discharge showed improvement of her tandem gait and full resolution of her left eye esotropia and ophthalmoplegia. Because of normal thiamine level and improvement in her symptoms, supplementation was discontinued. She continues to follow up with neurology and ophthalmology on a regular basis to monitor gait, thiamine levels, and vision. Discussion WE has many potential risk factors such as alcohol abuse, repeated vomiting, malignancy, gastrointestinal issues, and malnutrition—all of which cause thiamine deficiency.1 While hyperemesis gravidarum can also result in acute thiamine deficiency, it is not often associated with WE. WE presents with a triad of symptoms including ocular signs, ataxia, and confusion, and its presence during pregnancy may put patients at risk for permanent neurological dysfunction, Korsakoff syndrome, miscarriage, preterm birth, intrauterine growth restriction, and death.2,5,6 Although 70% to 90% of pregnant women experience nausea and vomiting, few develop hyperemesis gravidarum. Women who are experiencing prolonged or excessive vomiting should receive thiamine supplementation (usual dosing is 100 mg intramuscular (IM) or IV) to reduce the potential development of WE; however, higher doses are warranted when WE is diagnosed.4 Recommended dosing for thiamine supplementation in WE is 500 mg IV three times daily for 2 days, followed by 250 mg IV or IM once daily for an additional 5 days.7 It is important to emphasize the correct dosing for thiamine as inadequate thiamine dosing was reported in 63% of cases in the largest systematic review (177 cases). Age may also impact the severity of WE symptoms, with younger patients potentially having better outcomes, although more evidence is needed to say this with certainty.8 In our literature review, we were not able to identify a patient as young as ours. Providers must maintain a high index of suspicion for WE and monitor for ocular signs, ataxia, and confusion. Aggressive treatment with adequate thiamine dosing is critical to avoid potentially life-threatening complications for both the mother and fetus.\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2023-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/fm9.0000000000000198\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/fm9.0000000000000198","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

她在串联步态上也有一些困难。此时没有发现其他神经缺陷。脑部重复MRI显示先前MRI研究中先前异常的消退(图1C)。出院后约4个月,患者入院引产,妊娠39周时顺利顺产。这名婴儿的阿普加评分为7/8,出生体重为2920克。她失血很少,分娩后恢复得很好。她出院回家,情况稳定。分娩后,患者继续定期随访神经学,继续补充硫胺素,左眼异常和步态改善缓慢。出院后随访14个月,患者串联步态改善,左眼内斜视和眼肌麻痹完全消失。由于硫胺素水平正常且症状有所改善,停止补充。她继续定期进行神经病学和眼科随访,监测步态、硫胺素水平和视力。WE有许多潜在的危险因素,如酗酒、反复呕吐、恶性肿瘤、胃肠道问题和营养不良——所有这些都会导致硫胺素缺乏虽然妊娠剧吐也可导致急性硫胺素缺乏症,但它通常与WE无关。WE表现为三重症状,包括眼部体征、共济失调和精神错乱,妊娠期出现此病可能使患者面临永久性神经功能障碍、Korsakoff综合征、流产、早产、宫内生长受限和死亡的风险。2,5,6尽管70%至90%的孕妇会出现恶心和呕吐,但很少会出现妊娠剧吐。经历长期或过度呕吐的妇女应补充硫胺素(通常剂量为100mg肌肉注射(IM)或静脉注射)以减少WE的潜在发展;然而,当诊断为WE时,需要更高的剂量推荐的硫胺素补充剂量为每日三次,静脉注射500毫克,连续2天,然后每日一次,静脉注射或静脉注射250毫克,连续5天重要的是要强调硫胺素的正确剂量,因为在最大的系统评价(177例)中,63%的病例报告了硫胺素剂量不足。年龄也可能影响WE症状的严重程度,年轻的患者可能有更好的结果,尽管需要更多的证据来肯定这一点在我们的文献回顾中,我们无法确定像我们这样年轻的患者。医生必须对WE保持高度的怀疑,并监测眼部体征、共济失调和精神错乱。积极的治疗与适当的硫胺素剂量是至关重要的,以避免潜在的危及生命的并发症对母亲和胎儿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Wernicke-Korsakoff Syndrome from Hyperemesis Gravidarum
To editor: Wernicke encephalopathy (WE) is an acute neurological disorder caused by a deficiency of vitamin B1 (thiamine), with a prevalence of 1.3% in autopsy studies.1 Eighty-four percent of patients with WE will develop Korsakoff syndrome, which is characterized by amnesia and confusion.2 Although WE is more common in alcoholics, it can also be caused by vomiting, malnourishment, and other situations. Hyperemesis gravidarum, a severe form of vomiting in pregnancy affecting 0.3% to 3% of pregnancies, can also cause thiamine deficiency.3 Although there are no specific diagnostic criteria for hyperemesis gravidarum, it is generally defined as persistent vomiting in pregnancy that has no other identifiable cause. Risk factors of hyperemesis gravidarum include a family history of hyperemesis, multiple gestation, and history of hyperemesis gravidarum. Hyperemesis gravidarum can be associated with other complications such as nutritional deficiencies, esophageal injury, psychosocial effects, and poor fetal outcomes.3 We report a case of WE associated with hyperemesis gravidarum. This case suggests that providers should have a high degree of suspicion for WE and initiate early treatment in pregnant women with severe vomiting and neurologic symptoms.4 The patient provided informed consent for publication of this case. Case presentation A 16-year-old (gravida 1, para 0) patient was transferred to our institution from a local emergency department for inpatient care at 15+4 weeks of gestation secondary to hyperemesis, altered mental status, slurred speech, difficulty ambulating, visual changes, and difficulty hearing. Her mother reported nausea and vomiting for the past 2 months with emesis occurring 4 times a day. The family also reported other symptoms such as progressive weakness, amnesia, and excessive somnolence. She had a history of generalized anxiety disorder, major depressive disorder, and one prior episode of intentional overdose of acetaminophen before pregnancy. It is possible that her symptoms were not recognized earlier due to this history as the mother stated that the patient liked to be alone. She denied tobacco, alcohol, or drug use and did not have any other known risk factors for hyperemesis gravidarum. Initial examination at the outside emergency department showed that the patient had notable ataxia and was not oriented to time or location. However, she was able to follow simple commands and answer straightforward questions. At this time, differential diagnoses for her included metabolic encephalopathy, drug abuse, alcohol intoxication, intracranial hemorrhage, cerebrovascular accident, cavernous sinus thrombosis, hyperemesis gravidarum, viral syndrome, and seizures. Laboratory results, including complete blood count, alcohol level, urine drug screen and urinalysis, were all negative. A complete metabolic panel showed hypokalemia to 2.7 mEq/L. A computed tomography of the head with contrast was initially obtained to rule out acute intracranial abnormalities and was unremarkable. OB/GYN consultation was obtained and transfer with inpatient admission was recommended. After the transfer was accepted, she was given an initial dose of thiamine 100 mg intravenously (IV) and ondansetron while en route to our hospital. Because of the patient’s clinical picture, neurology consultation was obtained, and a magnetic resonance imaging (MRI) was performed. Routine multiplanar, multisequence, T2-weighted, diffusion-weighted, fluid-attenuated inversion recovery MRI of the brain showed symmetrical, abnormal restriction in the pulvinar and dorsomedial thalamic nuclei known as the “double hockey-stick sign” and the hyperintensity in the thalami, midbrain, and peri-aqueduct area, which are findings known to be associated with WE (Figure 1A and B).5Figure 1: Findings of brain magnetic resonance imaging with T2-weighted fluid-attenuated inversion recovery sequence. A On readmission with hyperemesis (white indicate double hockey-stick sign and the hyperintensity). B At 2 months after treatment with thiamine.The patient was started on thiamine 500 mg IV twice a day for 3 days followed by 250 mg IV for 5 days in addition to a multivitamin injection, folic acid, and vitamin B6. She was also started on famotidine in addition to scheduled ondansetron and doxylamine succinate/pyridoxine three times daily. Throughout her 10-day hospital stay, her condition significantly improved, and she had full resolution of her nausea, emesis, and abdominal pain. With resolution of the acute symptoms of WE, she was discharged to home with close follow-up. She was prescribed thiamine 100 mg daily and continued on doxylamine with pyridoxine, ondansetron, famotidine, and various prenatal supplements. At neurology follow-up 2 months after discharge, the patient complained of blurry vision in her left eye. On examination, left eye esotropia and ophthalmoplegia were noted, although it had improved from her previous examination. She also continued to have some difficulty in tandem gait. No other neurological deficits were seen at this time. A repeat MRI of the brain showed resolution of the previous abnormalities on the prior MRI study (Figure 1C). Approximately 4 months after discharge, the patient was admitted for induction of labor, and she had an uncomplicated spontaneous vaginal delivery at 39 weeks of gestation. The baby had Apgar scores of 7/8 and a birth weight of 2920 g. She had minimal blood loss and recovered well after delivery. She was discharged to home in stable condition. After delivery, the patient continued to follow up with neurology regularly and had slow improvement of her left eye abnormalities and gait with continued thiamine supplementation. Follow-up 14 months after discharge showed improvement of her tandem gait and full resolution of her left eye esotropia and ophthalmoplegia. Because of normal thiamine level and improvement in her symptoms, supplementation was discontinued. She continues to follow up with neurology and ophthalmology on a regular basis to monitor gait, thiamine levels, and vision. Discussion WE has many potential risk factors such as alcohol abuse, repeated vomiting, malignancy, gastrointestinal issues, and malnutrition—all of which cause thiamine deficiency.1 While hyperemesis gravidarum can also result in acute thiamine deficiency, it is not often associated with WE. WE presents with a triad of symptoms including ocular signs, ataxia, and confusion, and its presence during pregnancy may put patients at risk for permanent neurological dysfunction, Korsakoff syndrome, miscarriage, preterm birth, intrauterine growth restriction, and death.2,5,6 Although 70% to 90% of pregnant women experience nausea and vomiting, few develop hyperemesis gravidarum. Women who are experiencing prolonged or excessive vomiting should receive thiamine supplementation (usual dosing is 100 mg intramuscular (IM) or IV) to reduce the potential development of WE; however, higher doses are warranted when WE is diagnosed.4 Recommended dosing for thiamine supplementation in WE is 500 mg IV three times daily for 2 days, followed by 250 mg IV or IM once daily for an additional 5 days.7 It is important to emphasize the correct dosing for thiamine as inadequate thiamine dosing was reported in 63% of cases in the largest systematic review (177 cases). Age may also impact the severity of WE symptoms, with younger patients potentially having better outcomes, although more evidence is needed to say this with certainty.8 In our literature review, we were not able to identify a patient as young as ours. Providers must maintain a high index of suspicion for WE and monitor for ocular signs, ataxia, and confusion. Aggressive treatment with adequate thiamine dosing is critical to avoid potentially life-threatening complications for both the mother and fetus.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信